[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fS_oIvz0pG3Q7gm39PIEGRkBRpvk-oPCWeEPQPZV7MM4":8,"$fhzmqa7gRVf1ADimgno4SP_MApmkkpBgcVJap2fp37k8":59,"$fqnQIk0W9EYJqxuUwJaDxCovzv9bt1llzUnFOLYN19Ow":60,"$fGc2R8WuEj-RYD-e-ob-Ipc3dNpdJ4vRDqhogxpQSUFs":64},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":58},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":6,"adept":17,"hospital":18,"department":19,"postsTitle":20,"materialTotal":21,"videoTotal":22,"isConcern":7,"title":23,"coverVertical":24,"coverAcross":25,"directionMarker":26,"description":27,"vid":28,"time":29,"mediaType":26,"views":30,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":31,"seoTitle":32,"seoKeywords":33,"seoDescription":34,"shelvesTime":35,"menus":36,"menuId":38,"type":55,"quality":6,"commentCount":21,"isComment":26,"deviceType":56,"url":57},15672,871846,[],"https://yst.tos-cn-shanghai.volces.com/venue%2Fundefined%2F2025-12-16-16%3A11%3A04%2F76060049-1dff-40f7-88f3-c646c1d87a63.png","姜盈缨","社区常见病及慢性病的规范化诊疗","上海市浦东新区金杨社区卫生服务中心","全科医疗","主治医师",0,5,"感染后咳嗽的中医药治疗思考","","https://cdn.yishi-tong.com/console/3/KnOIyeRE8BubQS66FGCFGK6XNMxvs-yy.png",1,"WEBVTT\n\n00:02.661 --> 00:03.335\n大家好，\n\n00:03.335 --> 00:08.260\n我是金阳社区卫生服务中心的姜莹莹江医生。\n\n00:08.911 --> 00:15.760\n今天跟大家介绍一下感染后咳嗽的中医药治疗思考。\n\n00:19.735 --> 00:22.834\n感染后咳嗽的认识，\n\n00:23.235 --> 00:27.135\n咳嗽是呼吸系统最常见的症状，\n\n00:28.034 --> 00:33.784\n它一般分为急性咳嗽、亚急性咳嗽和慢性咳嗽。\n\n00:39.199 --> 00:40.699\n感染后咳嗽，\n\n00:41.798 --> 00:43.048\n西医认为，\n\n00:43.048 --> 00:47.098\n当呼吸道感染的急性期症状消失后，\n\n00:47.098 --> 00:49.499\n咳嗽仍然迁延不愈，\n\n00:49.749 --> 00:51.648\n持续3.8周，\n\n00:51.999 --> 00:56.298\nX线胸片检查无明显异常，\n\n00:57.249 --> 01:01.898\n以病毒性感冒引起的咳嗽最为常见，\n\n01:01.898 --> 01:04.249\n又称感冒后咳嗽。\n\n01:04.999 --> 01:06.848\n中医认为气道。\n\n01:08.128 --> 01:12.079\n高敏感性是风咳的共同特征，\n\n01:12.829 --> 01:17.579\n病因机制为外风引出内风，\n\n01:18.128 --> 01:19.679\n肺失宣肃，\n\n01:19.878 --> 01:21.179\n肺气上逆，\n\n01:21.329 --> 01:22.728\n遍身咳嗽。\n\n01:28.260 --> 01:37.209\n感染后咳嗽的病因感染后咳嗽的病理生理机制尚未完全明确。\n\n01:37.360 --> 01:44.209\n现代研究认为感染后咳嗽与气道炎症密切相关，\n\n01:44.660 --> 01:47.959\n是多种因素综合作用的结果。\n\n01:50.445 --> 01:55.146\n感染后咳嗽的治疗原则常为自限性，\n\n01:55.496 --> 01:57.346\n多能自行缓解。\n\n01:57.846 --> 02:01.096\n对部分咳嗽症状明显的患者，\n\n02:01.096 --> 02:04.195\n建议短期应用镇咳药，\n\n02:04.195 --> 02:10.046\n如右美沙芬、抗组胺药加减充血剂。\n\n02:12.167 --> 02:16.567\n感染后咳嗽不建议使用抗感染药物。\n\n02:20.027 --> 02:20.628\n可以。\n\n02:26.802 --> 02:32.251\n2021版咳嗽指南对PIC的治疗推荐。\n\n02:35.141 --> 02:38.041\n病毒性PIC不必使用。\n\n02:38.966 --> 02:40.667\n抗菌药物治疗，\n\n02:41.117 --> 02:44.266\n对部分咳嗽症状明显的患者，\n\n02:44.266 --> 02:50.417\n建议短期应用镇咳药、抗组胺药加减充血剂。\n\n02:55.330 --> 03:00.929\n复方甲氧那明治疗PIC有一定效果，\n\n03:00.929 --> 03:06.880\n不建议使用吸入性糖皮质激素和孟鲁司特钠治疗PIC。\n\n03:08.914 --> 03:14.014\n采用苏黄止咳胶囊治疗PC有一定的效果。\n\n03:20.317 --> 03:23.466\n苏黄止咳胶囊相关的研究。\n\n03:25.229 --> 03:26.979\n苏黄止咳胶囊，\n\n03:26.979 --> 03:27.604\n单药，\n\n03:27.604 --> 03:29.679\n现代药理学研究，\n\n03:30.080 --> 03:32.529\n它有炙麻黄，\n\n03:32.979 --> 03:34.029\n紫苏叶，\n\n03:34.179 --> 03:34.880\n地龙，\n\n03:34.979 --> 03:35.979\n枇杷叶，\n\n03:36.479 --> 03:37.479\n紫苏子，\n\n03:37.580 --> 03:38.330\n蝉蜕，\n\n03:38.779 --> 03:39.630\n前胡。\n\n03:41.602 --> 03:42.951\n等药物组成，\n\n03:43.701 --> 03:48.052\n芝麻黄有松弛支气管平滑肌的作用，\n\n03:48.451 --> 03:54.102\n紫苏叶有抑制花生四烯酸代谢途径中。\n\n03:55.067 --> 04:05.817\n环氧酶C的生成及活性减少该途径产生炎性介质前列腺素PGE2的含量。\n\n04:06.117 --> 04:07.317\n对A、a经。\n\n04:08.412 --> 04:16.613\n脱氧脂途径代谢产生的炎症介质白三烯有一定拮抗效应。\n\n04:18.213 --> 04:18.912\n地龙，\n\n04:19.213 --> 04:24.412\n地龙明显的增强巨噬细胞的免疫活性。\n\n04:24.863 --> 04:28.312\n地龙提取物对抗组胺的作用。\n\n04:30.244 --> 04:33.445\n五味子有镇咳祛痰作用，\n\n04:33.894 --> 04:36.295\n增强细胞免疫功能。\n\n04:36.695 --> 04:44.144\n蝉蜕抗可以抗支气管哮喘的气道炎症作用。\n\n04:52.282 --> 04:55.833\n苏黄治疗PIC作用机制。\n\n04:57.355 --> 04:57.555\n嗯，\n\n04:57.605 --> 04:59.855\n与这个通路有关。\n\n05:07.787 --> 05:16.537\n苏meta分析苏黄止咳胶囊治疗PIC有效性和安全性研究设计，\n\n05:16.888 --> 05:26.638\n本是本次meta分析共纳入7项涉及五十百七十三名患者的RCT研究。\n\n05:27.984 --> 05:29.910\n在干预措施方面，\n\n05:29.910 --> 05:33.434\n治疗组均采用苏黄止咳胶囊，\n\n05:33.885 --> 05:36.834\n对照组分别采用中成药。\n\n05:38.311 --> 05:43.360\n益肺止咳胶囊和止咳宁咳胶囊，\n\n05:43.460 --> 05:51.760\n及西药复方甲氧那明胶囊及复方磷酸可待因口服液。\n\n05:52.061 --> 05:53.311\n研究目的。\n\n05:54.315 --> 06:02.165\n旨在系统评估苏黄止咳胶囊对人成人感染后咳嗽的临床疗效。\n\n06:02.565 --> 06:03.915\n研究结论，\n\n06:04.114 --> 06:07.364\n与常规西药和其他中药相比，\n\n06:07.765 --> 06:13.464\n一、苏黄止咳胶囊可以有效提高治疗有效率，\n\n06:13.915 --> 06:21.415\n二、苏黄止咳胶囊还可以提高中医症候的治疗有效率。\n\n06:21.515 --> 06:24.364\n三、苏黄止咳胶囊在。\n\n06:24.631 --> 06:34.330\n临床应用中安全性良好发生率、不良反应发生率0.7%。\n\n06:42.070 --> 06:46.820\n苏黄止咳胶囊治疗儿童感染后咳嗽研究。\n\n06:49.375 --> 06:50.549\n研究目的，\n\n06:50.549 --> 06:57.674\n观察苏黄止咳胶囊治疗儿童感染后咳嗽的有效性及安全性。\n\n06:57.674 --> 07:05.125\n研究方法选例57例儿童感染后咳嗽且中医辨证。\n\n07:06.097 --> 07:08.048\n诊断为风咳症，\n\n07:08.398 --> 07:12.548\n随机分为观察组29例，\n\n07:12.697 --> 07:15.648\n采用苏黄止咳胶囊治疗，\n\n07:15.947 --> 07:17.847\n对照组28例，\n\n07:17.847 --> 07:20.847\n采用咳愈糖浆治疗。\n\n07:21.148 --> 07:24.247\n疗程7天。\n\n07:24.347 --> 07:28.997\n观察治疗前后患儿咳嗽症状评分，\n\n07:29.497 --> 07:32.747\n疗效自评及安全性指标。\n\n07:33.197 --> 07:36.398\n研究结果1观察组。\n\n07:36.571 --> 07:44.670\n咳嗽症状评分和疗效自评总有效率均显著高于对照组二。\n\n07:44.971 --> 07:51.471\n通过治疗后各年龄段咳嗽症状总评分比较观察，\n\n07:51.471 --> 07:55.371\n组6.12岁大于十二岁年龄段，\n\n07:55.371 --> 08:03.071\n咳嗽症状总评分改善情况显著优于对照组3。\n\n08:03.121 --> 08:05.770\n治疗过程中两组均未。\n\n08:06.558 --> 08:08.907\n现不良反应发生。\n\n08:11.598 --> 08:16.398\n苏黄止咳胶囊治疗老年感染后咳嗽研究。\n\n08:18.152 --> 08:19.427\n研究目的，\n\n08:19.427 --> 08:27.101\n苏观察苏黄止咳胶囊对感染后咳嗽老年患者动态血压影响。\n\n08:27.652 --> 08:28.951\n研究结果，\n\n08:29.601 --> 08:34.101\n用药后第3天第7天动态血压。\n\n08:35.754 --> 08:40.203\n与用药前比较无统计学差异。\n\n08:41.054 --> 08:43.604\n二、苏黄止咳胶囊。\n\n08:46.453 --> 08:49.453\n并不影响老年人的血压。\n\n08:53.541 --> 08:53.940\n了。\n\n09:09.000 --> 09:09.250\n嗯。\n\n09:14.450 --> 09:19.901\n苏黄止咳胶囊治疗PC的RCT研究进展。\n\n09:24.932 --> 09:25.333\n嗯。\n\n09:31.341 --> 09:31.690\n嗯，\n\n09:32.091 --> 09:34.541\n主评价的指标，\n\n09:34.591 --> 09:36.491\n主要疗效评价，\n\n09:36.791 --> 09:41.091\n咳嗽症状积分有效性评价。\n\n09:43.468 --> 09:52.718\n咳嗽症状积分在用药的第一天和用药结束后第九天，\n\n09:52.919 --> 09:58.818\n研究对患者进行咳嗽严重程度的评分评价。\n\n09:59.318 --> 10:04.268\n一是对患者咳嗽严重程度进行评分，\n\n10:04.318 --> 10:12.818\n评价咳嗽严重程度方法采用我国咳嗽治咳嗽的。\n\n10:13.478 --> 10:19.478\n诊断与治疗指南推荐的咳嗽积分量化指标。\n\n10:21.328 --> 10:23.078\n有效性评价，\n\n10:23.429 --> 10:28.278\n根据咳嗽症状积分评分表的标准，\n\n10:28.778 --> 10:33.879\n判断治疗后与治疗前咳嗽积分变化情况，\n\n10:34.229 --> 10:37.528\n分为四个评价体系痊愈。\n\n10:38.565 --> 10:41.315\n显效、有效和无效。\n\n10:44.369 --> 10:45.669\n评价指标，\n\n10:45.669 --> 10:47.669\n次要疗效评价，\n\n10:48.119 --> 10:50.919\n咳嗽症状起效时间，\n\n10:51.219 --> 10:58.719\n以咳嗽症状积分降低一个等级的时间判定为起效时间。\n\n10:59.219 --> 11:01.395\n咳嗽症状消失时间，\n\n11:01.395 --> 11:09.169\n以咳嗽症状完全消失的时候时间判定为咳嗽消失时间。\n\n11:10.669 --> 11:20.070\n安全性评价用于分析的安全性指标包括患者的所有不适主诉，\n\n11:20.719 --> 11:22.895\n生命体征啊，\n\n11:22.895 --> 11:24.719\n如体温、呼吸，\n\n11:24.719 --> 11:26.219\n心率、血压，\n\n11:26.520 --> 11:27.770\n肝肾功能，\n\n11:28.119 --> 11:29.169\n心电图。\n\n11:34.206 --> 11:47.257\n研究结果主要疗效入组患者基线特征包括人口学资料、现病史、既往疾病史、吸烟过敏史等。\n\n11:47.706 --> 11:50.656\n在两组间总体上分布。\n\n11:51.796 --> 11:52.596\n均衡，\n\n11:52.945 --> 11:55.745\n主要疗效指标两组，\n\n11:55.745 --> 12:00.695\n咳嗽症状和有效性评价无统计学差异。\n\n12:02.039 --> 12:03.239\n研究结果，\n\n12:03.239 --> 12:04.440\n次要疗效，\n\n12:04.789 --> 12:08.815\n两组咳嗽症状起效时间相当，\n\n12:08.815 --> 12:12.390\n两组间未见明显差异。\n\n12:15.544 --> 12:18.794\n安全性分析安全性结果，\n\n12:19.395 --> 12:22.294\n试验药物安全性良好，\n\n12:22.294 --> 12:24.695\n发生的较多见，\n\n12:24.744 --> 12:31.445\n不良反应主要为心悸、恶心、腹部不适和口干，\n\n12:31.844 --> 12:35.344\n严重程度均为轻度，\n\n12:35.395 --> 12:38.494\n试验期间未发现实验室。\n\n12:39.286 --> 12:41.086\n指标异常变化，\n\n12:41.236 --> 12:46.536\n未发现新的或重要的安全性问题，\n\n12:46.586 --> 13:09.637\n试验组和对照组均无严重不良反应导致退出不良事件、导致退出不良反应、导致暂停或永久停药不良事件、导致暂停或永久停药不良反应和导致采取措施不良反应。\n\n13:09.736 --> 13:10.385\n发生。\n\n13:11.770 --> 13:13.120\n研究结论，\n\n13:13.120 --> 13:22.820\n在本项多中心随机双盲阳性药物平行对照研究的四期临床研究，\n\n13:23.620 --> 13:25.171\n在疗效方面，\n\n13:25.171 --> 13:27.921\n使用实验药物后，\n\n13:28.721 --> 13:35.695\n对照组遇险率略高于试验组遇险率，\n\n13:35.695 --> 13:39.221\n组间比较差异无统计学意义。\n\n13:39.770 --> 13:41.770\n在安全性方面。\n\n13:41.971 --> 13:44.622\n试验药物安全性良好，\n\n13:44.921 --> 13:49.322\n未发现新的或重要的安全性问题。\n\n13:49.721 --> 14:02.721\n试验组和对照组在不良事件发生率、实验室检查生命体征和心电图变化情况组间无明显差异。\n\n14:04.122 --> 14:06.473\n本研究结果说明，\n\n14:07.023 --> 14:12.172\n苏黄止咳胶囊在PIC治疗的有效性上。\n\n14:13.330 --> 14:16.580\n不劣于复方甲氧纳米胶囊。\n\n14:18.018 --> 14:18.768\n总结，\n\n14:19.318 --> 14:25.068\n感染后咳嗽是亚急性咳嗽的常见病因，\n\n14:25.669 --> 14:33.119\n气道炎症和气道高反应性是感染后咳嗽的主要发病机制。\n\n14:33.768 --> 14:35.518\n研究证实，\n\n14:35.518 --> 14:41.468\n苏黄可以抑制气道高反应性和气道炎症。\n\n14:44.945 --> 14:46.895\n临床研究证实，\n\n14:47.094 --> 14:51.445\n苏黄对感染后咳嗽治疗有效，\n\n14:51.844 --> 14:56.344\n且效果不亚于复方甲氧那明胶囊。\n\n14:59.455 --> 15:00.655\n谢谢大家，\n\n15:01.354 --> 15:03.255\n今天的汇报结束了。\n\n","v0247cg10004d753fqaljhtcmmb4l5sg",907,588,"2026-01-30 00:08:12"," 感染后咳嗽的中医药治疗思考 - 中医理论与临床实践  \n"," 感染后咳嗽, 中医药治疗, 中医调理, 咳嗽中医方剂, 呼吸道感染后遗症, 中医养生, 咳嗽辨证施治  \n"," 本视频深入探讨感染后咳嗽的中医药治疗策略，结合中医理论分析咳嗽的病因病机，分享临床辨证施治经验，并提供实用中药方剂与调理建议，帮助缓解顽固性咳嗽并促进身体恢复。","2026-06-11 17:20:04",[37],{"menuId":38,"menuName":39,"parentId":21,"orderNum":40,"path":41,"component":42,"isFrame":43,"isCache":44,"menuType":45,"visible":26,"status":21,"createDept":6,"remark":24,"createTime":46,"children":47,"columnImage":48,"columnLogo":49,"uncheckedLogo":6,"checkedLogo":6,"isHot":21,"isHome":21,"forceLogin":21,"color":6,"seoTitle":50,"seoKeywords":51,"seoDescription":52,"contentNum":6,"promotionalPoster":53,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":54,"routerPath":41,"componentInfo":42},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video",2,4,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/871846/d3917b14-effb-4dd5-893d-deb466c5af3f.tmp?a=0&auth_key=1789013895-623cb8dadfb2468e8bb6960aa817d17a-0-d2aea3f7101a44c5d84900eb23522b3c&br=316&bt=316&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=3&eid=v0247cg10004d753fqaljhtcmmb4l5sg&er=0&l=202608110203094C0E9D61E52FE3456E76&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=ajg3cGZrb3Q2OjczNGY3M0Apdm9lcHdtZGk4ZzMzajo1eWdwaV9qcWdeYzJhLS1kNC9zc2QyMWpgZWluMDQxLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":57,"message":6,"data":6,"success":58},{"code":9,"msg":10,"message":6,"data":61,"success":58},{"pageNo":26,"pageSize":62,"result":63,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":65,"success":58},{"authors":66,"appraiseDimensionScoresVos":67},[],[]]